A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer
AbstractThe appearance of aberrant glycans on the tumor cell surface is one of the emerging hallmarks of cancer. Glycosylation is an important post-translation modification of proteins and lipids and is strongly affected by oncogenesis. Tumor-associated glycans have been extensively characterized regarding their composition and tumor-type specific expression patterns. Nevertheless whether and how tumor-associated glycans contribute to the observed immunomodulatory actions by tumors has not been extensively studied. Here, we provide a detailed overview of the current knowledge on how tumor-associated O-glycans affect the anti-tumor immune response, thereby focusing on truncated O-glycans present on epithelial tumors and mucins. These tumor-associated O-glycans and mucins bind a variety of lectin receptors on immune cells to facilitate the subsequently induction of tolerogenic immune responses. We, therefore, postulate that tumor-associated glycans not only support tumor growth, but also actively contribute to immune evasion. View Full-Text
Share & Cite This Article
Cornelissen, L.A.; Van Vliet, S.J. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer. Biomolecules 2016, 6, 26.
Cornelissen LA, Van Vliet SJ. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer. Biomolecules. 2016; 6(2):26.Chicago/Turabian Style
Cornelissen, Lenneke A.; Van Vliet, Sandra J. 2016. "A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer." Biomolecules 6, no. 2: 26.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.